Oral vancomycin: treatment of primary sclerosing cholangitis in children with inflammatory bowel disease.
Cox
K L
KL
Department of Pediatrics, Lucile Salter Packard Children's Hospital at Stanford University, Palo Alto, California 94304, USA.
Cox
K M
KM
D000284:Administration, Oral; D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001706:Biopsy; D002760:Cholangiopancreatography, Endoscopic Retrograde; D015209:Cholangitis, Sclerosing / Q000150:complications* / Q000188:drug therapy* / Q000473:pathology; D003093:Colitis, Ulcerative / Q000150:complications*; D003424:Crohn Disease / Q000150:complications*; D005260:Female; D006801:Humans; D008297:Male; D014640:Vancomycin / Q000008:administration & dosage / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D014640:Vancomycin